Back
Esquire Financial Holdings Vs. Viking Therapeutics Industry Stock Comparison
Sell
43
ESQ
Esquire Financial Holdings
Last Price:
47.69
Seasonality Move:
3.61%
Sell
44
VKTX
Viking Therapeutics
Last Price:
52.96
Seasonality Move:
1.76%
Sell
43
Esquire Financial Holdings (ESQ)
is a Sell
Is Esquire Financial Holdings a Buy, Sell or Hold?
- The current Esquire Financial Holdings [ESQ] share price is $46.74. The Score for ESQ is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- ESQ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $50.77. The Score for VKTX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ESQ Stock Price Chart
What is Esquire Financial Holdings's stock price today?
-
The Esquire Financial Holdings share price today is $46.74
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ESQ is experiencing buying pressure, which is a positive indicator for future bullish movement.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $50.77
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
ESQ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.37 | Sell |
| Relative Strength Index (14 RSI): | 53.06 | Buy |
| Chaikin Money Flow: | 28985 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.5 - 46.88) | Buy |
| Bollinger Bands (100): | (46 - 49.28) | Sell |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.32 | Sell |
| Relative Strength Index (14 RSI): | 38.16 | Sell |
| Chaikin Money Flow: | 2857375 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.57 - 61.31) | Sell |
| Bollinger Bands (100): | (46.52 - 79.44) | Sell |
ESQ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 45.73 | Buy |
| 20-day SMA: | 46.05 | Buy |
| 50-day SMA: | 47.13 | Sell |
| 200-day SMA: | 47.47 | Sell |
| 8-day EMA: | 45.96 | Buy |
| 20-day EMA: | 46.21 | Buy |
| 50-day EMA: | 46.83 | Sell |
| 200-day EMA: | 46.95 | Sell |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.48 | Buy |
| 20-day SMA: | 54.1 | Sell |
| 50-day SMA: | 63.93 | Sell |
| 200-day SMA: | 39 | Buy |
| 8-day EMA: | 50.61 | Buy |
| 20-day EMA: | 54.34 | Sell |
| 50-day EMA: | 59.63 | Sell |
| 200-day EMA: | 45.62 | Buy |
Esquire Financial Holdings Earnings Growth & ESQ Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.08 per share, an increase this year of $0.35 per share, and an increase next year of $0.51 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.43 per share.
Esquire Financial Holdings Technical Analysis
| Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||